(S (NP (NP (DT An) (NN outbreak)) (PP (IN of) (NP (NP (DT a) (JJ novel) (NN coronavirus)) (ADJP (NN disease) (PRN (-LRB- -LRB-) (ADVP (FW i.e.)) (, ,) (NP (NN COVID) (HYPH -) (CD 19)) (-RRB- -RRB-)))))) (VP (VBZ has) (VP (VBN been) (VP (VBN recorded) (PP (IN in) (NP (NP (NP (NNP Wuhan) (, ,) (NNP China)) (PP (IN since) (NP (JJ late) (NNP December) (CD 2019)))) (, ,) (SBAR (WHNP (WDT which)) (S (ADVP (RB subsequently)) (VP (VBD became) (NP (NN pandemic)) (PP (IN around) (NP (DT the) (NN world))))))))))) (. .))
(S (SBAR (IN Although) (S (NP (NN COVID) (HYPH -) (CD 19)) (VP (VBZ is) (NP (DT an) (ADJP (RB acutely) (VBN treated)) (NN disease))))) (, ,) (NP (PRP it)) (VP (MD can) (ADVP (RB also)) (VP (VB be) (ADJP (JJ fatal)) (PP (IN with) (NP (NP (DT a) (NN risk)) (PP (IN of) (NP (NP (NN fatality)) (PP (IN of) (NP (NP (NP (CD 4.03) (NN %)) (PP (IN in) (NP (NNP China)))) (CC and) (NP (NP (DT the) (JJS highest)) (PP (IN of) (NP (NP (NP (CD 13.04) (NN %)) (PP (IN in) (NP (NNP Algeria)))) (CC and) (NP (NP (CD 12.67) (NN %)) (NP (NNP Italy)))))))))))) (SBAR (-LRB- -LRB-) (IN as) (FRAG (PP (IN of) (NP (JJ 8th) (NNP April) (CD 2020)))) (-RRB- -RRB-)))) (. .))
(S (NP (NP (DT The) (NN onset)) (PP (IN of) (NP (JJ serious) (NN illness)))) (VP (MD may) (VP (VB result) (PP (IN in) (NP (NN death))) (PP (IN as) (NP (NP (DT a) (NN consequence)) (PP (IN of) (NP (NP (JJ substantial) (JJ alveolar) (NN damage)) (CC and) (NP (JJ progressive) (JJ respiratory) (NN failure)))))))) (. .))
(S (SBAR (IN Although) (S (NP (NP (NN laboratory) (NN testing)) (, ,) (ADVP (FW e.g.))) (, ,) (S (VP (VBG using) (NP (NML (JJ reverse) (NN transcription)) (NN polymerase) (NN chain) (NN reaction) (PRN (-LRB- -LRB-) (NP (NN RT) (HYPH -) (NN PCR)) (-RRB- -RRB-))))) (, ,) (VP (VBZ is) (NP (NP (DT the) (JJ golden) (NN standard)) (PP (IN for) (NP (JJ clinical) (NN diagnosis))))))) (, ,) (NP (DT the) (NNS tests)) (VP (MD may) (VP (VB produce) (NP (JJ false) (NNS negatives)))) (. .))
(S (ADVP (RB Moreover)) (, ,) (PP (IN under) (NP (DT the) (NN pandemic) (NN situation))) (, ,) (NP (NP (NN shortage)) (PP (IN of) (NP (NML (NN RT) (HYPH -) (NN PCR)) (NN testing) (NNS resources)))) (VP (MD may) (ADVP (RB also)) (VP (VB delay) (NP (NP (DT the) (VBG following) (JJ clinical) (NN decision)) (CC and) (NP (NN treatment))))) (. .))
(S (PP (IN Under) (NP (JJ such) (NNS circumstances))) (, ,) (NP (NML (NN chest) (NN CT)) (NN imaging)) (VP (VBZ has) (VP (VBN become) (NP (DT a) (JJ valuable) (NN tool)) (PP (IN for) (NP (NP (DT both) (NN diagnosis) (CC and) (NN prognosis)) (PP (IN of) (NP (NML (NN COVID) (HYPH -) (CD 19)) (NNS patients))))))) (. .))
(S (PP (IN In) (NP (DT this) (NN study))) (, ,) (NP (PRP we)) (VP (VBP propose) (NP (DT a) (ADJP (RB weakly) (JJ supervised)) (NML (JJ deep) (NN learning)) (NN strategy)) (PP (IN for) (S (VP (VBG detecting) (CC and) (VBG classifying) (NP (NML (NN COVID) (HYPH -) (CD 19)) (NN infection)) (PP (IN from) (NP (NN CT) (NNS images))))))) (. .))
(S (NP (DT The) (JJ proposed) (NN method)) (VP (MD can) (VP (VP (VB minimise) (NP (NP (DT the) (NNS requirements)) (PP (IN of) (NP (NP (JJ manual) (NN labelling)) (PP (IN of) (NP (NN CT) (NNS images))))))) (CC but) (ADVP (RB still)) (VP (VB be) (ADJP (JJ able) (S (VP (TO to) (VP (VB obtain) (NP (JJ accurate) (NN infection) (NN detection))))))) (CC and) (VP (VB distinguish) (NP (NNP COVID) (HYPH -) (NNP 19)) (PP (IN from) (NP (JJ non-COVID-19) (NNS cases)))))) (. .))
(S (PP (VBN Based) (PP (IN on) (NP (NP (DT the) (JJ promising) (NNS results)) (VP (VBN obtained) (ADVP (RB qualitatively) (CC and) (RB quantitatively)))))) (, ,) (NP (PRP we)) (VP (MD can) (VP (VB envisage) (NP (NP (DT a) (JJ wide) (NN deployment)) (PP (IN of) (NP (NP (PRP$ our) (VBN developed) (NN technique)) (PP (IN in) (NP (NML (JJ large) (HYPH -) (NN scale)) (JJ clinical) (NNS studies)))))))) (. .))
